Stealth BioTherapeutics Corp. - ADS (MITO): Price and Financial Metrics
Stealth BioTherapeutics Corp. - ADS (MITO):
GET POWR RATINGS...
MITO Price/Volume Stats
Stealth BioTherapeutics Corp. - ADS (MITO) Company Bio
A biopharmaceutical company developing therapies to treat the mitochondrial dysfunction associated with genetic mitochondrial diseases and many common age-related diseases.
MITO Latest News Stream
All News Types
Loading, please wait...
Latest MITO News From Around the Web
Below are the latest news stories about Stealth BioTherapeutics Corp that investors may wish to consider to help them evaluate MITO as an investment opportunity.
Stealth BioTherapeutics Corp (MITO) Q4 2020 Results Earnings Conference Call April 06, 2021, 08:30 AM ET Company Participants Henry Hess - Chief Legal Counsel Reenie McCarthy - Chief Executive Officer Jim Carr - Chief Clinical Development Officer Rob Weiskopf - Chief Financial Officer Brian Blakey - Chief Business Officer Conference...
Read More 'MITO' Stories Here
MITO Price Returns
Page generated in 0.682 seconds.